Winton Group LTD Abiomed Inc Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$300.63 - $371.35 $1.48 Million - $1.83 Million	-4,937 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$310.19 - $376.2 $911,028 - $1.1 Million	2,937 Added 146.85%	4,937 $1.61 Million
Q2 2021 Aug 10, 2021	SELL	$262.71 - $351.17 $316,040 - $422,457	-1,203 Reduced 37.56%	2,000 $624,000
Q1 2021 Jul 21, 2021	BUY	$285.92 - $355.13 $237,599 - $295,113	831 Added 35.03%	3,203 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $8,563 - $11,022	34 Added 1.45%	2,372 $769,000
Q3 2020 Oct 30, 2020	SELL	$255.22 - $317.0 $2.98 Million - $3.71 Million	-11,689 Reduced 83.33%	2,338 $648,000
Q2 2020 Aug 05, 2020	BUY	$141.4 - $257.09 $632,058 - $1.15 Million	4,470 Added 46.77%	14,027 $3.39 Million
Q1 2020 May 11, 2020	BUY	$130.51 - $196.01 $946,850 - $1.42 Million	7,255 Added 315.16%	9,557 $1.39 Million
Q4 2019 Feb 13, 2020	SELL	$159.31 - $223.54 $3.62 Million - $5.07 Million	-22,696 Reduced 90.79%	2,302 $393,000
Q3 2019 Nov 08, 2019	BUY	$175.89 - $279.23 $3.83 Million - $6.08 Million	21,769 Added 674.17%	24,998 $4.45 Million
Q2 2019 Jul 08, 2019	BUY	$250.96 - $284.94 $6,775 - $7,693	27 Added 0.84%	3,229 $841,000
Q1 2019 May 13, 2019	SELL	$276.39 - $362.25 $238,524 - $312,621	-863 Reduced 21.23%	3,202 $914,000
Q4 2018 Feb 05, 2019	BUY	$281.08 - $444.25 $157,123 - $248,335	559 Added 15.94%	4,065 $1.32 Million
Q3 2018 Nov 02, 2018	SELL	$354.53 - $449.75 $10.5 Million - $13.3 Million	-29,561 Reduced 89.4%	3,506 $0
Q2 2018 Aug 20, 2018	BUY	$278.07 - $446.21 $6.67 Million - $10.7 Million	23,999 Added 264.66%	33,067 $0
Q1 2018 May 21, 2018	BUY	$192.49 - $295.85 $1.75 Million - $2.68 Million	9,068 New	9,068 $0

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account